UP!

ALGN $335.24   View long term graphs

Align Technology, Inc.
Type
Public
Traded as
  • NASDAQ: ALGN
  • NASDAQ-100 component
  • S&P 500 component
Industry Orthodontics devices
Founded 1997
Founders Zia Chishti, Kelsey Wirth
Headquarters San Jose, California, USA
Area served
Worldwide
Key people
Joseph M. Hogan
(President) & (CEO)
Products clear aligners, scanners
Revenue Increase $ 1.080 billion(FY 2016)
Operating income
Increase $ 248.92 million (FY 2016)
Net income
Increase $ 189.68 million (FY 2016)
Total assets Increase $ 1.396 billion (FY 2016)
Total equity Increase $ 995.39 million (FY 2016)
Number of employees
6,060 (Dec 2016)
Website www.aligntech.com

Align Technology is a manufacturer of 3D digital scanners and a clear aligners used in orthodontics. It is headquartered in San Jose, California; it manufactures the aligners in Juarez, Mexico and its scanners in Israel.

Align Technology was founded by Zia Chishti and Kelsey Wirth in 1997 and began working on the development of a clear aligner. Align received FDA clearance to market the Invisalign system in 1998 and it was first marketed in 2000. Align Technology went public on January 26, 2001 on the Nasdaq Stock Market.

In 2010 the company received a warning letter from the FDA regarding its failure to report serious reactions to Invisalign.

In March 2011 Align acquired the Israeli company Cadent for $190 million; Cadent manufactured intraoral cameras that included 3D scanners, as well as software to display the acquired images and to plan treatment.

Joseph M. Hogan joined Align in June 2015, and serves as CEO and President. As of 2016 it had 6,060 employees worldwide.

The company's sales reached $1 billion for the first time in 2016 and its products were being used in about 8% of people who got braces. In 2017 the company was faced with the challenge of the expiration of its patents on its Invisalign system starting in October 2017 and the beginning of generic competition.

News

Align Technology, Inc. 3.64% (healthcare)

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q4 2020 2021-01-27 Future report Set alerts
Q3 2020 2020-10-21 Future report Set alerts
Q2 2020 2020-07-22 -0.35 -0.52
Q1 2020 2020-04-29 0.73 19.21
Q4 2019 2020-01-29 1.53 1.53
Q3 2019 2019-10-23 1.28 1.28
Q2 2019 2019-07-24 1.83 1.83
Q1 2019 2019-04-24 0.89 0.89
Q4 2018 2019-01-29 1.20 1.20
Q3 2018 2018-10-24 1.24 1.24

Ratings

2016-06-04 Reiterated Rating Credit Suisse Buy
2016-06-04 Reiterated Rating Robert W. Baird Buy
2016-06-04 Reiterated Rating Leerink Swann Buy
2016-06-04 Reiterated Rating Credit Suisse Group AG Buy
2016-05-17 Reiterated Rating Piper Jaffray Overweight $74.00 to $82.00
2016-05-17 Reiterated Rating Piper Jaffray Cos. Overweight $74.00 to $82.00
2016-05-14 Reiterated Rating Morgan Stanley Buy
2016-05-11 Initiated Coverage Credit Suisse Outperform $84.00
2016-04-29 Reiterated Rating Morgan Stanley Buy $84.00
2016-04-29 Reiterated Rating Jefferies Group Buy $85.00
2016-03-24 Reiterated Rating Canaccord Genuity Buy $72.00 to $80.00
2016-03-23 Boost Price Target Roth Capital Buy $72.00 to $80.00
2016-03-08 Reiterated Rating Piper Jaffray Buy
2016-01-29 Reiterated Rating Roth Capital Buy
2016-01-29 Reiterated Rating William Blair Buy
2016-01-29 Boost Price Target Robert W. Baird Outperform $72.00 to $74.00
2016-01-29 Reiterated Rating Leerink Swann Outperform $75.00 to $81.00
2016-01-29 Boost Price Target Jefferies Group Buy $72.00 to $75.00
2016-01-29 Boost Price Target Goldman Sachs Buy $67.00 to $72.00
2016-01-29 Boost Price Target Stifel Nicolaus Buy $80.00 to $82.00
2016-01-29 Boost Price Target Goldman Sachs Group Inc. Buy $67.00 to $72.00
2016-01-20 Reiterated Rating Roth Capital Buy
2015-11-18 Initiated Coverage Piper Jaffray Overweight $74.00
2015-10-25 Reiterated Rating Leerink Swann Buy $70.00 to $75.00
2015-10-23 Reiterated Rating William Blair Outperform
2015-10-23 Boost Price Target Robert W. Baird Outperform $68.00 to $72.00
2015-10-23 Boost Price Target Jefferies Group Buy $70.00 to $72.00
2015-10-23 Boost Price Target Stifel Nicolaus Buy $75.00 to $80.00
2015-10-20 Reiterated Rating Roth Capital Buy
2015-09-11 Initiated Coverage Leerink Swann Outperform $70.00
2015-07-24 Boost Price Target Stifel Nicolaus Buy $70.00 to $75.00
2015-07-16 Reiterated Rating Roth Capital Buy
2015-06-19 Reiterated Rating Roth Capital Buy $72.00
2015-04-24 Reiterated Rating Stifel Nicolaus Buy $65.00 to $70.00
2015-04-24 Set Price Target Roth Capital Buy $62.00 to $72.00
2015-04-21 Upgrade Morgan Stanley Equal Weight to Overweight $56.00 to $79.00
2015-02-03 Lower Price Target Roth Capital Buy $66.00 to $62.00
2015-01-30 Lower Price Target Jefferies Group Buy $72.00 to $70.00
2015-01-30 Downgrade JMP Securities Outperform to Market Perform $63.00
2015-01-26 Set Price Target Roth Capital Buy $66.00 to $62.00
2015-01-02 Upgrade Robert W. Baird Neutral to Outperform $53.00 to $64.00
2014-10-24 Upgrade Jefferies Group Hold to Buy $62.00
2014-10-20 Upgrade Credit Suisse Neutral to Outperform $58.00
2014-10-20 Upgrade Goldman Sachs Neutral to Buy
2014-07-25 Reiterated Rating Jefferies Group Hold $55.00 to $60.00
2014-04-24 Reiterated Rating Credit Suisse Neutral $58.00
2014-04-24 Reiterated Rating Cantor Fitzgerald Positive
2014-04-07 Upgrade Barrington Research Market Perform to Outperform $67.00
2014-04-04 Reiterated Rating Cantor Fitzgerald Buy
2014-01-31 Boost Price Target Roth Capital $56.00 to $66.00
2014-01-31 Boost Price Target JMP Securities $64.00 to $74.00
2014-01-29 Boost Price Target Stifel Nicolaus Buy $60.00 to $65.00
2014-01-28 Boost Price Target Cantor Fitzgerald $60.00 to $65.00
2013-10-18 Reiterated Stifel Buy $54 to $57
2013-10-18 Boost Price Target Roth Capital Buy $46.00 to $56.00
2013-10-18 Boost Price Target Jefferies Group Hold $43.00 to $52.00
2013-10-18 Reiterated Rating Robert W. Baird Hold $49.00
2013-10-18 Boost Price Target Stifel Nicolaus Buy $54.00 to $57.00
2013-10-18 Upgrade Cantor Fitzgerald Hold to Buy $42.00 to $60.00
2013-10-04 Downgrade Robert W. Baird Outperform to Neutral $49.00
2013-09-17 Reiterated Stifel Buy $46 to $54
2013-09-17 Boost Price Target Stifel Nicolaus Buy $46.00 to $54.00
2013-07-19 Reiterated Stifel Buy $43 to $46
2013-07-19 Reiterated Cantor Fitzgerald Hold $40 to $42
2013-07-10 Reiterated Stifel Buy $40 to $43
2013-07-02 Initiated Robert W. Baird Outperform $45
2013-06-17 Reiterated Stifel Buy $38 to $40
2013-02-04 Reiterated Stifel Nicolaus Buy $32 to $38
2012-11-08 Initiated Stifel Nicolaus Buy $32
2012-10-18 Reiterated Cantor Fitzgerald Hold $37 to $32
2012-09-17 Downgrade Cantor Fitzgerald Buy to Hold $37
2012-05-22 Initiated Cantor Fitzgerald Buy $37
2012-04-25 Reiterated Barrington Research Outperform $28 to $38
2012-02-01 Reiterated Barrington Research Outperform $24 to $28
2012-01-31 Reiterated JMP Securities Mkt Outperform $26 to $29
2011-12-16 Initiated William Blair Outperform
2010-09-15 Initiated JMP Securities Mkt Outperform $23
2016-06-04 Reiterated Rating Credit Suisse Buy
2016-06-04 Reiterated Rating Robert W. Baird Buy
2016-06-04 Reiterated Rating Leerink Swann Buy
2016-06-04 Reiterated Rating Credit Suisse Group AG Buy
2016-05-17 Reiterated Rating Piper Jaffray Overweight $74.00 to $82.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
DANAHER CORP /DE/ 4.75%  (3837132) ALGN / DHR /
LACOB JOSEPH 0.37%  (296264) ALGN / OREX /
PRESCOTT THOMAS M President and CEO 0.17%  (140399) ALGN /
LARKIN C RAYMOND JR 0.10%  (83201) ALGN / HTWR /
HEDGE LEN SVP, Business Operations 0.07%  (55861) ALGN /
MORROW GEORGE J 0.06%  (51400) ALGN / NBIX / OTIC / SWY / VICL /
HOGAN JOSEPH M President and CEO 0.06%  (50211) ALGN /
Thaler Warren S 0.06%  (47400) ALGN /
Wright Emory VP, Operations 0.05%  (41823) ALGN /
Pascaud Raphael VP, International 0.04%  (35587) ALGN /
AROLA KENNETH VP, Finance and CFO 0.04%  (31682) ALGN / EXTR /
NAGEL DAVID C 0.04%  (30200) ALGN / TSRA / UPIP / VG /
Kolli Sreelakshmi VP, Info Technology 0.03%  (28180) ALGN /
COLLINS DAVID E 0.03%  (25900) ALGN /
Relic Zelko VP, Research & Development 0.03%  (24534) ALGN /
Tay Julie VP, Asia Pacific 0.02%  (19866) ALGN /
SANTORA GREG J 0.02%  (19000) ALGN / SALE /
Saia Andrea Lynn 0.02%  (18133) ALGN / CCE /
WHITE DAVID L CFO 0.01%  (11549) ALGN /
Erfurth Jennifer VP, Global HR 0.01%  (10760) ALGN /
Olson Jennifer VP& Mng Dir. D-DCC 0.01%  (9487) ALGN /
Puco Christopher C. VP, No. American Sales 0.01%  (8623) ALGN /
GEORGE ROGER E VP,Leg. Affairs & Gen. Counsel 0.01%  (8068) ALGN /
Beard Simon VP and Mgng Director, EMEA 0.01%  (7472) ALGN /
Hockridge Stuart A VP, Global Human Resources 0.01%  (4856) ALGN /
Twomey Richard M.L. VP, International 0.01%  (4272) ALGN /

Comments